Historical salary details - Dr. Samarth Kulkarni, PhD, Chairman of the Board and Chief Executive Officer, CRISPR Therapeutics AG
Dr. Samarth Kulkarni, PhD has been the Chairman of the Board and Chief Executive Officer of CRISPR Therapeutics AG since 16 May 2018 and his latest salary was 33.2 M. View his historical salary.
Dr. Samarth Kulkarni, Phd
Chairman of the Board and Chief Executive Officer
$ 33.2 M
Gross Remuneration
-
Current Company
CRISPR Therapeutics AG
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | CRISPR Therapeutics AG | Chairman of the Board and Chief Executive Officer | 33.2 M | 169.2 % |
| 2023 | CRISPR Therapeutics AG | Chairman of the Board and Chief Executive Officer | 12.3 M | -40.6 % |
| 2022 | CRISPR Therapeutics AG | Chief Executive Officer and Director | 20.7 M | 21.7 % |
| 2021 | CRISPR Therapeutics AG | - | 17.0 M | 87.1 % |
| 2021 | CRISPR Therapeutics AG | Chief Executive Officer and Director | 17.0 M | 87.1 % |
| 2020 | CRISPR Therapeutics AG | - | 9.1 M | -44.0 % |
| 2020 | CRISPR Therapeutics AG | Chief Executive Officer and Director | 9.1 M | -44.0 % |
| 2020 | CRISPR Therapeutics AG | - | 9.1 M | -44.0 % |
| 2019 | CRISPR Therapeutics AG | - | 16.3 M | 67.3 % |
| 2019 | CRISPR Therapeutics AG | Chief Executive Officer and Director | 16.3 M | 67.3 % |
| 2019 | CRISPR Therapeutics AG | - | 16.3 M | 67.3 % |
| 2018 | CRISPR Therapeutics AG | Chief Executive Officer and Director | 9.7 M | 51.3 % |
| 2018 | CRISPR Therapeutics AG | - | 9.7 M | 51.3 % |
| 2018 | CRISPR Therapeutics AG | - | 9.7 M | 51.3 % |
| 2017 | CRISPR Therapeutics AG | - | 6.9 M | - |
| 2017 | CRISPR Therapeutics AG | - | 6.9 M | - |
| 2017 | CRISPR Therapeutics AG | Chief Executive Officer | 6.4 M | - |
| 2016 | CRISPR Therapeutics AG | - | 1.3 M | -9.7 % |
| 2016 | CRISPR Therapeutics AG | - | 1.3 M | -9.7 % |
| 2016 | CRISPR Therapeutics AG | Chief Business Officer | - | - |
| 2015 | CRISPR Therapeutics AG | Chief Business Officer | 1.5 M | - |